FindTrial
Sign In

A Medical Records Based Research of Dosimetry, Radiobiology, and Quality Control for Liver Cancer, Lung Cancer, and Intracranial Tumors in Stereotactic Body Radiation Therapy.

The Research of Dosimetry, Radiobiology, and Quality Control for Liver Cancer, Lung Cancer, and Intracranial Tumors in Stereotactic Body Radiation Therapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038112
Enrollment
Unknown
Registered
2020-09-11
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cancer, Lung Cancer, Intracranial Tumors

Interventions

SBRT group:No

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with liver cancer, lung cancer and intracranial tumor who underwent stereotactic body radiation therapy from January 2017 to September 2020 in the Radiotherapy Department of West China Hospital.

Exclusion criteria

Exclusion criteria: Patients with incomplete treatment data

Design outcomes

Primary

MeasureTime frame
? pass rate;—

Countries

China

Contacts

Public ContactGuangjun Li

West China Hospital, Sichuan University

gjnick829@sina.com+86 18980606702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026